ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Nightstar files for $86M IPO to fund gene therapy trials – FierceBiotech

FierceBiotechNightstar files for $86M IPO to fund gene therapy trialsFierceBiotechNightstar Therapeutics has filed to raise up to $86 million in a Nasdaq IPO. The money will equip Nightstar to complete a phase 3 trial of its choroideremia gene therapy … Continue reading

2017-09-01 Michael Zand NEWS

Gilead finds CAR-T manufacturing costly but says Kite’s is ‘superb’ and cost-efficient – FiercePharma

Continue reading

2017-09-01 Michael Zand NEWS

Ouachita professor Nathan Reyna invited to National Science Foundation-funded mentor program – Ouachita Baptist University News

Ouachita professor Nathan Reyna invited to National Science Foundation-funded mentor programOuachita Baptist University NewsCurrently, Ouachita has five CURE programs embedded into its curriculum, coordinated primarily by Dr. Reyna and Dr. Ruth Plymale… Continue reading

2017-09-01 Michael Zand NEWS

Ouachita professor Nathan Reyna invited to National Science Foundation-funded mentor program – Ouachita Baptist University News

Ouachita professor Nathan Reyna invited to National Science Foundation-funded mentor programOuachita Baptist University NewsCurrently, Ouachita has five CURE programs embedded into its curriculum, coordinated primarily by Dr. Reyna and Dr. Ruth Plymale… Continue reading

2017-09-01 Michael Zand NEWS

Healthwatch: Gene Therapy – WeAreGreenBay.com


FiercePharma

Gilead finds CAR–T manufacturing costly but says Kite’s is ‘superb’ and cost-efficient
FiercePharma
Gilead Sciences is betting nearly $12 billion on Kite Pharma’s CAR–T technology, and one of the factors that influenced it is Kite’s readiness to handle the complex and time-sensitive manufacturing and logistics demanded by the personalized cell …
Bio Roundup: CAR–T’s Huge Week, Merck’s ‘Pib Choice & MoreXconomy
Gilead’s Acquisition Of Kite Pharma Relieves Shareholders’ EnnuiSeeking Alpha

all 62 news articles »

Continue reading

2017-09-01 Michael Zand NEWS

America approves ‘revolutionary’ CAR T cell immunotherapy — what does this mean for cancer patients? – The Institute of Cancer Research (blog)


WeAreGreenBay.com

Healthwatch: Gene Therapy
WeAreGreenBay.com
GREEN BAY, Wis. (WFRV) – (CBS News) The Food and Drug Administration approved a treatment that engineers a patient’s own blood cells to fight cancer. It’s the first type of gene therapy to hit the U-S market. It has already been used to treat children …

Continue reading

2017-09-01 Michael Zand NEWS

FDA approves breakthrough gene therapy for childhood leukemia – KSDK


The Institute of Cancer Research (blog)

America approves ‘revolutionary’ CAR T cell immunotherapy — what does this mean for cancer patients?
The Institute of Cancer Research (blog)
The treatment, known as CAR T cell therapy, was shown to be effective against blood cancers in clinical trials, and has just been approved by the Food and Drug Administration in the US specifically for children and young adults who have acute …
Cancer treatment breakthrough just the beginning for new therapiesThe New Daily

all 4 news articles »

Continue reading

2017-09-01 Michael Zand NEWS

FDA announces actions regarding stem cell treatments – Lexology (registration)

FDA announces actions regarding stem cell treatmentsLexology (registration)Together with new guidance regarding the potential regulatory pathways for gene therapies, the FDA announced on Monday, August 28, 2017, that it will be taking action against co… Continue reading

2017-09-01 Michael Zand NEWS
  • 1
  • …
  • 1,261
  • 1,262
  • 1,263
  • 1,264
  • 1,265
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

KSDK

FDA approves breakthrough gene therapy for childhood leukemia
KSDK
The Food and Drug Administration said the approval on Wednesday was historic, the first gene therapy to hit the U.S. market. Made from scratch for every patient, it’s one of a wave of “living drugs” under development to fight additional blood cancers …
Pioneering gene therapy approved for leukaemia in the USNew Scientist
FDA approval brings first gene therapy to the United StatesFDA.gov
First Gene Therapy Treatment Approved in USSmithsonian
Los Angeles Times –Novartis –National Cancer Institute –National Cancer Institute
all 597 news articles »